Wellgistics pharmacy revenue grows to $0.6M in April 2026 from $0.1M in November 2025
Wellgistics Health reported Q1 2026 results showing sequential growth in pharmacy revenue and announced partnerships with Kare Pharmtech and Tollo Health to expand direct-to-patient capabilities, while terminating non-binding LOIs with Neuritek and WellCare. The company is advancing integration of its PharmacyChain and EinsteinRx technologies and preparing for an August 2026 product launch targeting 200,000+ patient lives.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day